• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组改变和相关的肠漏是否会影响 COVID-19 的严重程度?

Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?

机构信息

Division of Biosystems & Biomedical Sciences, College of Health Sciences, Korea University, Seoul, Republic of Korea

出版信息

mBio. 2021 Jan 12;12(1):e03022-20. doi: 10.1128/mBio.03022-20.

DOI:10.1128/mBio.03022-20
PMID:33436436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7845625/
Abstract

Coronavirus disease 2019 (COVID-19), which has been declared a pandemic, has exhibited a wide range of severity worldwide. Although this global variation is largely affected by socio-medical situations in each country, there is also high individual-level variation attributable to elderliness and certain underlying medical conditions, including high blood pressure, diabetes, and obesity. As both elderliness and the aforementioned chronic conditions are often associated with an altered gut microbiota, resulting in disrupted gut barrier integrity, and gut symptoms have consistently been associated with more severe illness in COVID-19 patients, it is possible that dysfunction of the gut as a whole influences COVID-19 severity. This article summarizes the accumulating evidence that supports the hypothesis that an altered gut microbiota and its associated leaky gut may contribute to the onset of gastrointestinal symptoms and occasionally to additional multiorgan complications that may lead to severe illness by allowing leakage of the causative coronavirus into the circulatory system.

摘要

2019 年冠状病毒病(COVID-19)已被宣布为大流行,在全球范围内表现出广泛的严重程度。尽管这种全球差异在很大程度上受到每个国家社会医疗状况的影响,但也存在由于高龄和某些潜在医疗状况(包括高血压、糖尿病和肥胖症)导致的个体水平的高度差异。由于高龄和上述慢性疾病通常与肠道微生物群的改变有关,导致肠道屏障完整性受损,而肠道症状与 COVID-19 患者更严重的疾病一直有关,因此,整个肠道功能障碍可能会影响 COVID-19 的严重程度。本文总结了越来越多的证据,支持这样一种假设,即肠道微生物群的改变及其相关的肠道渗漏可能导致胃肠道症状的发生,偶尔还会导致其他多器官并发症,通过允许致病冠状病毒进入循环系统,从而导致严重疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/e410b534c857/mBio.03022-20-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/0925814c37ab/mBio.03022-20-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/45d2f9160b4c/mBio.03022-20-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/e410b534c857/mBio.03022-20-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/0925814c37ab/mBio.03022-20-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/45d2f9160b4c/mBio.03022-20-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476f/7845625/e410b534c857/mBio.03022-20-f003.jpg

相似文献

1
Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?肠道微生物组改变和相关的肠漏是否会影响 COVID-19 的严重程度?
mBio. 2021 Jan 12;12(1):e03022-20. doi: 10.1128/mBio.03022-20.
2
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.由(SARS-CoV-2)感染引起的冠状病毒病(COVID-19):人类肠道微生物组的真正挑战。
Front Cell Infect Microbiol. 2020 Dec 9;10:575559. doi: 10.3389/fcimb.2020.575559. eCollection 2020.
3
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.2019 年冠状病毒病中肠道微生物组的改变及其治疗潜力。
World J Gastroenterol. 2022 Dec 21;28(47):6689-6701. doi: 10.3748/wjg.v28.i47.6689.
4
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.肠道细菌失调和不稳定与 COVID-19 并发症和死亡率的发生有关。
Gut Microbes. 2022 Jan-Dec;14(1):2031840. doi: 10.1080/19490976.2022.2031840.
5
Inflammatory effect on the gastrointestinal system associated with COVID-19.与 COVID-19 相关的胃肠道系统炎症效应。
World J Gastroenterol. 2021 Jul 14;27(26):4160-4171. doi: 10.3748/wjg.v27.i26.4160.
6
Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.营养调控肠道菌群可改善急性新冠后综合征患者的严重胃肠道症状。
mBio. 2022 Apr 26;13(2):e0380121. doi: 10.1128/mbio.03801-21. Epub 2022 Mar 7.
7
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.新型冠状病毒感染期间胃肠道紊乱的潜在原因和后果。
Cell Rep. 2020 Jul 21;32(3):107915. doi: 10.1016/j.celrep.2020.107915. Epub 2020 Jul 3.
8
SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?SARS-CoV-2 与本土微生物组的关联:肠道微生物组是否会导致 COVID-19 中的炎症和疾病严重程度增加?
Front Cell Infect Microbiol. 2021 Mar 11;11:590874. doi: 10.3389/fcimb.2021.590874. eCollection 2021.
9
Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 Cytokine Storm?肠道微生物群的扰动是否可能加剧 COVID-19 细胞因子风暴的严重程度?
Front Immunol. 2021 Jan 25;11:607734. doi: 10.3389/fimmu.2020.607734. eCollection 2020.
10
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2.肠道微生物组作为 SARS-CoV-2 易感性差异的生物标志物。
Trends Mol Med. 2021 Dec;27(12):1115-1134. doi: 10.1016/j.molmed.2021.09.009. Epub 2021 Oct 6.

引用本文的文献

1
Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19.新型冠状病毒感染中的微生物群失调:对2019冠状病毒病病理生理学和管理策略的影响
Front Cell Infect Microbiol. 2025 Apr 22;15:1537456. doi: 10.3389/fcimb.2025.1537456. eCollection 2025.
2
Inflammatory Markers and Severity in COVID-19 Patients with Clostridioides Difficile Co-Infection: A Retrospective Analysis Including Subgroups with Diabetes, Cancer, and Elderly.新冠病毒感染合并艰难梭菌感染患者的炎症标志物与疾病严重程度:一项包括糖尿病、癌症和老年亚组的回顾性分析
Biomedicines. 2025 Jan 17;13(1):227. doi: 10.3390/biomedicines13010227.
3

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
SARS-CoV-2 viral load is associated with increased disease severity and mortality.SARS-CoV-2 病毒载量与疾病严重程度和死亡率的增加有关。
Nat Commun. 2020 Oct 30;11(1):5493. doi: 10.1038/s41467-020-19057-5.
3
Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
Neurological, psychological, psychosocial complications of long-COVID and their management.
新冠长期症状的神经、心理、社会心理并发症及其管理。
Neurol Sci. 2025 Jan;46(1):1-23. doi: 10.1007/s10072-024-07854-5. Epub 2024 Nov 9.
4
Gut microbiota and its metabolic products in acute respiratory distress syndrome.急性呼吸窘迫综合征中的肠道微生物群及其代谢产物
Front Immunol. 2024 Feb 16;15:1330021. doi: 10.3389/fimmu.2024.1330021. eCollection 2024.
5
The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).新冠病毒病(COVID-19)对代谢功能障碍相关脂肪性肝病(MASLD)进展的长期影响。
Cureus. 2023 Sep 14;15(9):e45231. doi: 10.7759/cureus.45231. eCollection 2023 Sep.
6
Herbal medicine in the treatment of COVID-19 based on the gut-lung axis.基于肠-肺轴的中药治疗新型冠状病毒肺炎
Acupunct Herb Med. 2022 Sep;2(3):172-183. doi: 10.1097/HM9.0000000000000038. Epub 2022 Dec 8.
7
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy.新冠病毒感染中的肠道微生物群失调:调节以及预防和治疗方法
Int J Mol Sci. 2023 Jul 31;24(15):12249. doi: 10.3390/ijms241512249.
8
The plasma metabolome of long COVID patients two years after infection.长新冠患者感染两年后的血浆代谢组。
Sci Rep. 2023 Aug 1;13(1):12420. doi: 10.1038/s41598-023-39049-x.
9
Gastrointestinal microbiome of ARDS patients induces neuroinflammation and cognitive impairment in mice.ARDS 患者的胃肠道微生物组会在小鼠中引发神经炎症和认知障碍。
J Neuroinflammation. 2023 Jul 15;20(1):166. doi: 10.1186/s12974-023-02825-7.
10
Inulin Prebiotic Protects against Lethal Acute Infection via γδ T Cell Activation.菊粉益生元通过 γδ T 细胞激活来预防致死性急性感染。
Nutrients. 2023 Jul 5;15(13):3037. doi: 10.3390/nu15133037.
意大利 COVID-19 患者的尸检结果:有和无合并症病例的描述性全面尸检研究。
J Infect Dis. 2020 Nov 9;222(11):1807-1815. doi: 10.1093/infdis/jiaa578.
4
Modeling the Onset of Symptoms of COVID-19.建模 COVID-19 症状的发作。
Front Public Health. 2020 Aug 13;8:473. doi: 10.3389/fpubh.2020.00473. eCollection 2020.
5
Pathologic features of COVID-19: A concise review.COVID-19 的病理学特征:简要回顾。
Pathol Res Pract. 2020 Sep;216(9):153097. doi: 10.1016/j.prp.2020.153097. Epub 2020 Jul 4.
6
Extrapulmonary complications of COVID-19: A multisystem disease?COVID-19 的肺外并发症:一种多系统疾病?
J Med Virol. 2021 Jan;93(1):323-335. doi: 10.1002/jmv.26294. Epub 2020 Jul 22.
7
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
8
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗?
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
9
Ageing, metabolism and the intestine.衰老、代谢与肠道。
EMBO Rep. 2020 Jul 3;21(7):e50047. doi: 10.15252/embr.202050047. Epub 2020 Jun 21.
10
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.